Edward J. Hollox

Edward J. Hollox

Auto-generated profile, based on publicly available information

Edward J. Hollox

University of Leicester

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EHEdward J Hollox
Edward J Hollox
UHUlrike Huffmeier
Ulrike Huffmeier
PZPatrick Zeeuwen
Patrick Zeeuwen
RPRaquel Palla
Raquel Palla
JLJesús Lascorz
Jesús Lascorz
JSJoost Schalkwijk
Joost Schalkwijk

1 September 2003 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
EHE.J. Hollox
E.J. Hollox
JAJ.A.L. Armour
J.A.L. Armour
JBJ.C.K. Barber
J.C.K. Barber

8 June 2005 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
PAPatricia M.R. Aldred
Patricia M.R. Aldred
EHEdward J. Hollox
Edward J. Hollox
JAJohn A.L. Armour
John A.L. Armour
We have defined unexpectedly extensive copy number variation at the human anti-microbial α-defensin genes DEFA1 and DEFA3, encoding human neutrophil peptides HNP-1, HNP-2 and HNP-3. There was variation in both number and position of DEFA1/DEFA3 genes in arrays of 19 kb tandem repeats on 8p23.1, so that the DEFA1 and DEFA3 genes appear to be interchangeable variant cassettes within tandem gene arrays. For this reason, the official symbol for this locus has been revised to DEFA1A3. The total number of gene copies per diploid genome varied between four and 11 in a sample of 111 control individuals from the UK, with ∼10% (11/111) of people lacking DEFA3 completely. DEFA1 appeared to be at high copy number in all great apes studied; at one variable site in the repeat unit, both variants have persisted in humans, chimpanzees and gorillas since their divergence. Analysis of expression levels in human white blood cells showed a clear correlation between the relative proportions of DEFA1:DEFA3 mRNA and corresponding gene numbers. However, there was no relationship between total (DEFA1+DEFA3) mRNA levels and total gene copy number, suggesting the superimposed influence of trans-acting factors. The persistence of DEFA1 at high copy number in other apes suggests an alternative model for the early stages of the evolution of novel genes by duplication and divergence. Duplicated genes present in variant tandem arrays may have greater potential than simple duplications for the combinatorial creation of new functions by recombination and gene conversion, while still preserving pre-existing functions on the same haplotype.

6 March 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PJPatrick A. M. Jansen
Patrick A. M. Jansen
DRDiana Rodijk-Olthuis
Diana Rodijk-Olthuis
EHEdward J. Hollox
Edward J. Hollox
MKMarijke Kamsteeg
Marijke Kamsteeg
GTGeuranne S. Tjabringa
Geuranne S. Tjabringa
JSJoost Schalkwijk
Joost Schalkwijk
Previous studies have extensively documented antimicrobial and chemotactic activities of beta-defensins. Human beta-defensin-2 (hBD-2) is strongly expressed in lesional psoriatic epidermis, and recently we have shown that high beta-defensin genomic copy number is associated with psoriasis susceptibility. It is not known, however, if biologically and pathophysiologically relevant concentrations of hBD-2 protein are present in vivo, which could support an antimicrobial and proinflammatory role of beta-defensins in lesional psoriatic epidermis. We found that systemic levels of hBD-2 showed a weak but significant correlation with beta defensin copy number in healthy controls but not in psoriasis patients with active disease. In psoriasis patients but not in atopic dermatitis patients, we found high systemic hBD-2 levels that strongly correlated with disease activity as assessed by the PASI score. Our findings suggest that systemic levels in psoriasis are largely determined by secretion from involved skin and not by genomic copy number. Modelling of the in vivo epidermal hBD-2 concentration based on the secretion rate in a reconstructed skin model for psoriatic epidermis provides evidence that epidermal hBD-2 levels in vivo are probably well above the concentrations required for in vitro antimicrobial and chemokine-like effects. Serum hBD-2 appears to be a useful surrogate marker for disease activity in psoriasis. The discrepancy between hBD-2 levels in psoriasis and atopic dermatitis could explain the well known differences in infection rate between these two diseases.

1 January 2001 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
EHEdward J. Hollox
Edward J. Hollox
MPMark Poulter
Mark Poulter
MZMarek Zvarik
Marek Zvarik
VFVladimir Ferak
Vladimir Ferak
AKAmanda Krause
Amanda Krause
DSDallas M. Swallow
Dallas M. Swallow

20 July 2011 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
TTTheodore L. Tollner
Theodore L. Tollner
SVScott A. Venners
Scott A. Venners
EHEdward J. Hollox
Edward J. Hollox
AYAshley I. Yudin
Ashley I. Yudin
XLXue Liu
Xue Liu
GCGary N. Cherr
Gary N. Cherr
A frequent frameshift mutation in defensin DEFB126 , a protein that adheres to the surface of human sperm, weakens its ability to penetrate cervical mucus-like gels and causes low fertility.